Home
Series of Journals
Literature
Latest literature
Popular literature
About us
Intro
Organizational structure
Job Responsibilities
Copyright
Contact us
The title
The title
The keywords
The author
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University
Home
Results
The title
The title
The keywords
The author
A total of
2172
result was found. Results that relate to
M
Comparative analysis of antibacterial activity of Perilla Folium with different leaf colors and its correlation with leaf color values and chemical constituents
Published on
Frontiers in Pharmaceutical Sciences
2026,30(5):787-794.
928 times
177 times
LIU Wenli
YANG Meiqin
LI Lingxi
NIE Lixing
KANG Shuai
YU Jiandong
CHENG Xianlong
LIN Yongqiang
WEI Feng
Perilla Foliu
m
Antibacterial activity
Color values
Che
m
ical co
m
position
Correlation
Details
Evaluation of the effects of different sterilization methods on the quality of Amomi Fructus raw powder evaluated by AHP-entropy weight TOPSIS
Published on
Frontiers in Pharmaceutical Sciences
2026,30(5):795-803.
859 times
159 times
CAO Ling
SHI Guoli
CUI Linlin
GAO Yanhong
WANG Ning
LIU Yuanhui
JIN Zongyuan
LI Weiqun
A
m
o
m
i Fructus
Raw powder
AHP-entropy weight TOPSIS
Dry heat sterilization
M
oist heat sterilization
Ultraviolet sterilization
Irradiation sterilization
Details
Simultaneous determination of 10 impurities in ibuprofen and its preparations by UPLC method
Published on
Frontiers in Pharmaceutical Sciences
2026,30(5):804-812.
870 times
161 times
YUN Xiaofei
ZHANG Yanxia
QIAN Yujuan
HAN Feng
XIAO Honghua
YAN Zeman
WANG Meng
Ibuprofen
Ultra-perfor
m
ance liquid chro
m
atography
I
m
purities
Toxicity
Quality control
Details
Retrospective study on the efficacy of insulin degludec/insulin aspart combined with dietary management in patients with type 2 diabetes mellitus
Published on
Frontiers in Pharmaceutical Sciences
2026,30(5):813-819.
847 times
159 times
XIANG Yuyang
XIE Yuye
LIN Zhihao
Type 2 diabetes
m
ellitus
Insulin degludec/insulin aspart
Integrated diet
m
anage
m
ent
m
odel
Efficacy observation
Details
Establishment of drug utilization evaluation criteria for bemiparin sodium and its clinical application
Published on
Frontiers in Pharmaceutical Sciences
2026,30(5):820-827.
852 times
161 times
YE Chenli
HONG Weimin
HAN Yutong
CAO Weiling
Be
m
iparin sodiu
m
Drug utilization evaluation
Delphi
m
ethod
Off-label use
Rational drug use
Details
Research progress on herbal textual research and pharmacological effects of Changium smyrnioides Wolff
Published on
Frontiers in Pharmaceutical Sciences
2026,30(5):828-838.
998 times
186 times
DOU Haoran
LIU Yu
YI Bowen
Changiu
m
s
m
yrnioides Wolff
Processing
Efficacy
Herbal textual research
Phar
m
acological effects
Details
Research progress on food-medicine homology substances in metabolic dysfunc-tion-associated steatotic liver disease
Published on
Frontiers in Pharmaceutical Sciences
2026,30(5):839-847.
981 times
172 times
SUN Mingyu
LI Ming
ZHANG Hao
Food-
m
edicine ho
m
ology substances
M
etabolic dysfunction-associated steatotic liver disease
Lipid
m
etabolis
m
Liver fibrosis
M
echanis
m
of action
Details
Research progress on clinical application and mechanisms of traditional Chinese medicine formulas in postpartum hypogalactia
Published on
Frontiers in Pharmaceutical Sciences
2026,30(5):848-856.
921 times
143 times
CHENG Kun
FU Xianjun
LI Xiuxue
Postpartu
m
hypogalactia
Traditional Chinese
m
edicine for
m
ulas
Clinical research
Syndro
m
e differentiation
M
echanis
m
of action
Details
Research progress on multidrug resistance mechanism of non-small cell lung cancer and reversal effect of active ingredients of traditional Chinese medicine
Published on
Frontiers in Pharmaceutical Sciences
2026,30(5):857-866.
807 times
148 times
ZHENG Wanrong
LAI Fobao
Tu
m
or
m
ultidrug resistance
Non-s
m
all cell lung cancer
Active co
m
ponents of traditional Chinese
m
edicine
Resistance reversal
Non-coding RNA
Progra
m
m
ed cell death
Details
Research progress on traditional Chinese medicine combined with chemotherapeutic drugs in the treatment of colorectal cancer
Published on
Frontiers in Pharmaceutical Sciences
2026,30(5):867-875.
780 times
133 times
LIU Qingrui
WANG Lu
CHEN Hao
WANG Pei
HUANG Chuyue
ZHOU Bingwen
DONG Yujing
FAN Zhimin
Colorectal cancer
Traditional Chinese
m
edicine
Enhancing efficacy and reducing toxicity
Cell cycle
Autophagy
Apoptosis
M
ultidrug resistance
I
m
m
une
m
icroenviron
m
ent
Details
Research progress on optimized technical paths of meloxicam dosage forms
Published on
Frontiers in Pharmaceutical Sciences
2026,30(5):876-884.
710 times
137 times
YANG Jie
YUAN Jing
XU Shaohua
LIAO Zongquan
XIAO Gaofeng
QU Longmei
M
eloxica
m
Dosage for
m
Drug delivery syste
m
Targeted preparations
Sustained-release preparations
Cyclooxygenase-2
Details
Interpretation of the Guiding Principles of Good AI Practice in Drug Development jointly released by FDA and EMA
Published on
Frontiers in Pharmaceutical Sciences
2026,30(5):885-894.
1589 times
558 times
ZHANG Hua
LI Pengfei
FU Hongjun
U.S. Food and Drug Ad
m
inistration
European
M
edicines Agency
Ar-tificial intelligence
Drug develop
m
ent
Guide principles
Regulatory science
Details
Analysis of one case of almolertinib-induced interstitial lung disease in a lung cancer patient
Published on
Frontiers in Pharmaceutical Sciences
2026,30(5):895-900.
815 times
152 times
FAN Xinxing
LI Ling
ZHENG Menying
BAI Juan
Al
m
onertinib
Interstitial lung disease
Lung cancer
Adverse drug reaction
Details
Guide on Methodological Standards in Pharmacoepidemiology (2nd edition) and their series interpretation (18): analysis strategies and clinical applications of heterogeneity of treatment effect
Published on
Chinese Journal of Pharmacoepidemiology
2026,35(6):601-612.
335 times
96 times
HUANG Tao
SHEN Zhuoheng
XU Yang
Heterogeneity of treat
m
ent effect
Phar
m
acoepide
m
iology
Real-world data
Subgroup analysis
Risk
m
odelling
Effect
m
odelling
Causal
m
achine learning
Precision
m
edicine
Details
Interpretation of the Transparent Reporting of Observational Studies Emulating a Target Trial (TARGET) statement
Published on
Chinese Journal of Pharmacoepidemiology
2026,35(6):613-624.
313 times
80 times
LIN Tengfei
WU Xiaoyu
HE Na
LONG Yujun
YANG Nan
QIU Yijin
ZHANG Tiantian
XU Yang
YANG Zhirong
Observational study
Target trial e
m
ulation
Reporting guideline
TARGET state
m
ent
Causal inference
Details
上一页
1
2
136
137
138
139
140
141
142
143
144
145
下一页
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University